Home › Calculator › RAPP Dividend Calculator 2026
RAPP Dividend DRIP Calculator 2026
5.13% YieldHealthcareRapport Therapeutics, Inc. Common Stock · NASDAQ
Price: $38.97 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When RAPP pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your RAPP snowball 📈
$10,000 in RAPP → $16.5K in 10 years · $67.10/month
About Rapport Therapeutics, Inc. Common Stock (RAPP) — Dividend Analysis 2026
Rapport Therapeutics, Inc. functions as a clinical-phase biopharmaceutical enterprise, concentrating its efforts on discovering and developing innovative small-molecule therapeutics for individuals living with central nervous system (CNS) disorders. Its flagship product candidate, RAP-219, is an experimental small molecule precisely designed to inhibit TARPy8-containing AMPARs with exceptional potency (picomolar affinity). This promising compound aims to treat focal epilepsy and a range of other neurological conditions, including peripheral neuropathic pain and bipolar disorder. The company's pipeline further includes RAP-199, another molecule targeting TARPy8, which boasts distinct chemical and pharmacokinetic profiles. Moreover, Rapport is advancing several nicotinic acetylcholine receptor (nAChR) programs, such as an a6 nAChR therapy for chronic pain and an a9a10 nAChR treatment intended for hearing impairments. Formed in 2022 under the initial name Precision Neuroscience NewCo, Inc., the company adopted its current identity as Rapport Therapeutics, Inc. in October 2022, and its operations are based in Boston, Massachusetts.
Compare RAPP with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full RAPP DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open RAPP position with:
🌍 RAPP Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold RAPP.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 5.13% | 2.33% | $513 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 4.36% | 1.56% | $436 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 4.10% | 1.30% | $410 / yr |
| 🇬🇧 UK ISA | 0% | 5.13% | 2.33% | $513 / yr |
| 🇬🇧 UK Taxable | 8.75% | 4.68% | 1.88% | $468 / yr |
| 🇨🇦 TFSA | 0% | 5.13% | 2.33% | $513 / yr |
| 🇨🇦 CA Taxable | 25% | 3.85% | 1.05% | $385 / yr |
| 🇦🇺 Super (pension) | 15% | 4.36% | 1.56% | $436 / yr |
| 🇦🇺 AU Taxable | 30% | 3.59% | 0.79% | $359 / yr |
| 🇩🇪 DE Taxable | 26.375% | 3.78% | 0.98% | $378 / yr |
| 🇫🇷 FR Taxable | 30% | 3.59% | 0.79% | $359 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 RAPP Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 RAPP Dividend Payment Schedule
RAPP pays quarterly — 4 times per year. Next ex-div: TBD.
📊 RAPP vs Healthcare Benchmarks
How RAPP compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for RAPP sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ RAPP Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Sale | 2026-07-14 | 5,481 | $39.72 | $217.7K | ||
| Sale | 2026-07-14 | 2,729 | $40.57 | $110.7K | ||
| Sale | 2026-06-30 | 1,900 | $40.09 | $76.2K | ||
| Sale | 2026-06-30 | 3,792 | $41.39 | $157.0K | ||
| Sale | 2026-06-30 | 3,308 | $42.17 | $139.5K | ||
| Sale | 2026-06-30 | 1,000 | $43.15 | $43.2K | ||
| Sale | 2026-06-29 | 7,344 | $39.77 | $292.1K | ||
| Sale | 2026-06-29 | 876 | $40.34 | $35.3K | ||
| A-Award | 2026-06-10 | 15,200 | $35.21 | $535.2K | ||
| A-Award | 2026-06-10 | 15,200 | $35.21 | $535.2K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the RAPP dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Rapport Therapeutics, Inc. Common Stock (RAPP) is currently trading at $38.97, trading near its 52-week high. The current dividend yield is 5.13% based on an annual payout of $2.00 per share.
RAPP (Rapport Therapeutics, Inc. Common Stock) — 5.13% Dividend Yield Analysis
Rapport Therapeutics, Inc. Common Stock (RAPP) is a healthcare stock currently trading at $38.97 with a dividend yield of 5.13%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.